Aspirin Resistance Reversibility in Diabetic Patients

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is assessing the prevalence of aspirin resistance in a cohort of diabetic patients. Those found resistant has been undergone pharmacological tests using different drug formulations to investigate the reversibility of aspirin resistance.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Azienda Ospedaliera San Giovanni Battista
• Treatments: Acetylsalicylic acid lysinate; Aspirin

Criteria

Inclusion Criteria:

• diabete mellitus type 2

• asa since 30 days at least

• plts >150000 and <450000

Exclusion Criteria:

• recent ACS (within 30 days)

• anticoagulant therapy

• haemorragic diathesis